The in vivo results in glioblastoma-bearing rats demonstrated that NE-siRNA CD73 treatment by intranasal administration significantly decreased the glioma growth by 60% when compared to the control groups (untreated and NE-siRNA scramble). The gene discussed is NT5E; the disease is glioblastoma.